- Home
- AIRG vs IFRX Comparison
AIRG vs IFRX Comparison
Compare AIRG & IFRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRG
- IFRX
- Stock Information
- Founded
- AIRG 1995
- IFRX 2007
- Country
- AIRG United States
- IFRX Germany
- Employees
- AIRG N/A
- IFRX N/A
- Industry
- AIRG Radio And Television Broadcasting And Communications Equipment
- IFRX Biotechnology: Pharmaceutical Preparations
- Sector
- AIRG Technology
- IFRX Health Care
- Exchange
- AIRG Nasdaq
- IFRX Nasdaq
- Market Cap
- AIRG 48.7M
- IFRX 53.5M
- IPO Year
- AIRG 2016
- IFRX 2017
- Fundamental
- Price
- AIRG $5.04
- IFRX $0.90
- Analyst Decision
- AIRG Strong Buy
- IFRX Strong Buy
- Analyst Count
- AIRG 3
- IFRX 4
- Target Price
- AIRG $8.50
- IFRX $7.75
- AVG Volume (30 Days)
- AIRG 42.1K
- IFRX 356.2K
- Earning Date
- AIRG 08-06-2025
- IFRX 08-07-2025
- Dividend Yield
- AIRG N/A
- IFRX N/A
- EPS Growth
- AIRG N/A
- IFRX N/A
- EPS
- AIRG N/A
- IFRX N/A
- Revenue
- AIRG $58,381,000.00
- IFRX $140,242.00
- Revenue This Year
- AIRG N/A
- IFRX N/A
- Revenue Next Year
- AIRG $23.54
- IFRX $1,276.37
- P/E Ratio
- AIRG N/A
- IFRX N/A
- Revenue Growth
- AIRG 8.46
- IFRX 30.90
- 52 Week Low
- AIRG $3.17
- IFRX $0.71
- 52 Week High
- AIRG $10.34
- IFRX $2.82
- Technical
- Relative Strength Index (RSI)
- AIRG 64.50
- IFRX 52.02
- Support Level
- AIRG $4.19
- IFRX $0.82
- Resistance Level
- AIRG $5.71
- IFRX $0.89
- Average True Range (ATR)
- AIRG 0.43
- IFRX 0.06
- MACD
- AIRG 0.08
- IFRX 0.01
- Stochastic Oscillator
- AIRG 52.07
- IFRX 75.92
About AIRG Airgain Inc.
Airgain Inc is engaged in providing antenna technologies. These technologies can be used to enable performance wireless networking across devices and markets which include connected homes, enterprises, automotive, and the Internet of Things. It also provides solutions to complex radio frequency, engineering challenges, and improving wireless service that require higher throughput, broad coverage footprint, and carrier-grade quality. Geographically, it derives maximum revenue from North America and also has a presence in China and the Rest of the World. The company products include Antenna Plus: Fleet, M2M, IoT Antennas, Carrier-Class Antenna, Embedded Antennas, and External Dipole Antennas.
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.